We are live on ! Find out more
AYTU icon

AYTU BioPharma
AYTU

27 hedge funds and large institutions have $5.46M invested in AYTU BioPharma in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

23% more funds holding

Funds holding: 22 → 27 (+5)

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

9% more capital invested

Capital invested by funds: $5.03M → $5.46M (+$429K)

0.44% more ownership

Funds ownership: 31.79% → 32.23% (+0.44%)

Holders
27
Holders Change
+5
Holders Change %
+22.73%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$43.6K
2
Citadel Advisors
Citadel Advisors
Florida
+$34.8K
3
Renaissance Technologies
Renaissance Technologies
New York
+$6.87K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.34K
5
UBS Group
UBS Group
Switzerland
+$2.19K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$17.8K
2
Morgan Stanley
Morgan Stanley
New York
-$4.98K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$2.55K
4
Wells Fargo
Wells Fargo
California
-$20
5
Northern Trust
Northern Trust
Illinois
-$11
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$3.3M – – –
SCM
2
Stonepine Capital Management
Oregon
$1.44M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$217K +$6.87K +2,400 +3%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$105K +$4.34K +1,517 +5%
Vanguard Group
5
Vanguard Group
Pennsylvania
$84.8K +$1.82K +637 +2%
BlackRock
6
BlackRock
New York
$69.3K – – –
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$46.3K +$43.6K +15,240 New
Northern Trust
8
Northern Trust
Illinois
$44.3K -$11 -4 -0%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$44K – – –
Goldman Sachs
10
Goldman Sachs
New York
$42.2K – – –
Citadel Advisors
11
Citadel Advisors
Florida
$37K +$34.8K +12,175 New
TRCT
12
Tower Research Capital (TRC)
New York
$9.2K +$2.13K +743 +33%
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$8K -$2.55K -890 -25%
Morgan Stanley
14
Morgan Stanley
New York
$3.22K -$4.98K -1,740 -62%
UBS Group
15
UBS Group
Switzerland
$3.12K +$2.19K +766 +295%
JP Morgan Chase
16
JP Morgan Chase
New York
$1.89K -$17.8K -6,215 -91%
Osaic Holdings
17
Osaic Holdings
Arizona
$912 – – –
Wells Fargo
18
Wells Fargo
California
$498 -$20 -7 -4%
CIBC Private Wealth Group
19
CIBC Private Wealth Group
Georgia
$248 +$237 +83 New
Bank of America
20
Bank of America
North Carolina
$152 +$143 +50 New
Group One Trading
21
Group One Trading
Illinois
$112 – – –
NA
22
NewEdge Advisors
Louisiana
$64 – – –
HNB
23
Huntington National Bank
Ohio
$61 +$57 +20 New
WFA
24
West Financial Advisors
Iowa
$31 +$29 +10 New
CWM
25
CarsonAllaria Wealth Management
Illinois
$15 – – –
1
2

AYTU Hedge Fund Activity: Q1 2024 in Review

27 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q1 2024, worth a combined $5.46M — up 8.5% from $5.03M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new AYTU positions and 1 closed out — a net gain of 5 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Dimensional Fund Advisors, opening a new position worth an estimated $43.6K. The largest seller was JP Morgan Chase, cutting an estimated $17.8K.

  • 27 institutional investors held AYTU BioPharma (AYTU) as of Q1 2024, up from 22 in Q4 2023.
  • Funds reported $5.46M of AYTU BioPharma stock for Q1 2024, up 8.5% quarter-over-quarter.
  • 6 funds opened new AYTU BioPharma positions in Q1 2024 and 1 closed out, a net change of +5 holders.
  • The largest AYTU BioPharma buyer in Q1 2024 was Dimensional Fund Advisors, an estimated $43.6K added.
  • The largest AYTU BioPharma seller in Q1 2024 was JP Morgan Chase, an estimated $17.8K sold.

Based on aggregated 13F filings for Q1 2024.